| Source: |
| Type: |
| Memory |
| - | in-vivo, | AD, | NA |
| 5633- | BCA, | Mechanisms Behind the Pharmacological Application of Biochanin-A: A review |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 5565- | betaCar, | β-Carotene, a Potent Amyloid Aggregation Inhibitor, Promotes Disordered Aβ Fibrillar Structure |
| - | Study, | AD, | NA |
| 4061- | betaCar, | VitB12, | VitB6, | FA, | VitB3 | Revisiting the Role of Vitamins and Minerals in Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 4083- | betaCar, | Significance of vitamin A to brain function, behavior and learning |
| - | Review, | AD, | NA |
| 4082- | betaCar, | Marginal vitamin A deficiency facilitates Alzheimer's pathogenesis |
| - | Study, | AD, | NA |
| 5484- | BM, | The Neurocognitive Effects of Bacopa monnieri and Cognitive Training on Markers of Brain Microstructure in Healthy Older Adults |
| - | in-vivo, | AD, | NA |
| 5485- | BM, | Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis |
| - | Review, | AD, | NA |
| 5473- | BM, | Bacopa monnieri: Preclinical and Clinical Evidence of Neuroactive Effects, Safety of Use and the Search for Improved Bioavailability |
| - | in-vivo, | AD, | NA | - | in-vivo, | Park, | NA |
| 5474- | BM, | Pharmacological attributes of Bacopa monnieri extract: Current updates and clinical manifestation |
| 3696- | BM, | Discovery of Molecular Networks of Neuroprotection Conferred by Brahmi Extract in Aβ42-Induced Toxicity Model of Drosophila melanogaster Using a Quantitative Proteomic Approach |
| - | in-vivo, | NA, | NA |
| 3697- | BM, | Bacopa monnieri, a Neuroprotective Lead in Alzheimer Disease: A Review on Its Properties, Mechanisms of Action, and Preclinical and Clinical Studies |
| - | Review, | AD, | NA |
| 3691- | BM, | Effects of a Standardized Bacopa monnieri Extract on Cognitive Performance, Anxiety, and Depression in the Elderly: A Randomized, Double-Blind, Placebo-Controlled Trial |
| - | Study, | Nor, | NA |
| 3690- | BM, | Neurocognitive Effect of Nootropic Drug Brahmi (Bacopa monnieri) in Alzheimer's Disease |
| - | Review, | AD, | NA |
| 5663- | BNL, | Osthole/borneol thermosensitive gel via intranasal administration enhances intracerebral bioavailability to improve cognitive impairment in APP/PS1 transgenic mice |
| - | in-vivo, | AD, | NA |
| 3511- | Bor, | Boron |
| - | Review, | NA, | NA |
| 696- | Bor, | Nothing Boring About Boron |
| - | Review, | Var, | NA |
| 760- | Bor, | Therapeutic Efficacy of Boric Acid Treatment on Brain Tissue and Cognitive Functions in Rats with Experimental Alzheimer’s Disease |
| - | in-vivo, | AD, | NA |
| 4620- | Bor, | BTZ, | Boron Compounds in the Breast Cancer Cells Chemoprevention and Chemotherapy |
| - | Review, | Var, | NA | - | Review, | Arthritis, | NA | - | Review, | Pca, | NA |
| 4624- | Bor, | VitD3, | Boron as a Medicinal Ingredient in Oral Natural Health Products |
| - | Review, | Pca, | NA |
| 4270- | Bos, | Boswellic acids ameliorate neurodegeneration induced by AlCl3: the implication of Wnt/β-catenin pathway |
| - | in-vivo, | AD, | NA |
| 6549- | BSB, | (-)-α-bisabolol prevents neuronal damage and memory deficits through reduction of proinflammatory markers induced by permanent focal cerebral ischemia in mice |
| - | in-vivo, | Nor, | NA |
| 7832- | CA, | CGA, | MBS, | Neuroprotective Potential of Mung Bean (Vigna radiata L.) Polyphenols in Alzheimer's Disease: A Review |
| - | Review, | AD, | NA |
| 7516- | CA, | Caffeic Acid, a Polyphenolic Micronutrient Rescues Mice Brains against Aβ-Induced Neurodegeneration and Memory Impairment |
| - | in-vivo, | AD, | NA |
| 7515- | CA, | Protective role of caffeic acid in an Aβ25-35-induced Alzheimer's disease model |
| - | in-vivo, | AD, | NA |
| 4263- | CA, | Neuroprotective Effects of Carnosic Acid: Insight into Its Mechanisms of Action |
| - | Review, | AD, | NA |
| 3791- | CA, | Caffeic Acid and Diseases—Mechanisms of Action |
| - | Review, | AD, | NA |
| 5751- | CA, | Potential Therapeutic Implications of Caffeic Acid in Cancer Signaling: Past, Present, and Future |
| - | Review, | Var, | NA |
| 4267- | Caff, | Caffeine‐mediated BDNF release regulates long‐term synaptic plasticity through activation of IRS2 signaling |
| - | in-vivo, | NA, | NA |
| 4161- | Caff, | Chronic caffeine prevents changes in inhibitory avoidance memory and hippocampal BDNF immunocontent in middle-aged rats |
| - | in-vivo, | AD, | NA |
| 5860- | CAP, | Beneficial Effects of Capsaicin in Disorders of the Central Nervous System |
| - | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
| 2349- | CAP, | The TRPV1-PKM2-SREBP1 axis maintains microglial lipid homeostasis in Alzheimer’s disease |
| - | in-vivo, | AD, | NA |
| 5768- | CAPE, | Neuroprotective Potential of Caffeic Acid Phenethyl Ester (CAPE) in CNS Disorders: Mechanistic and Therapeutic Insights |
| - | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
| 7520- | CAPE, | Neuroprotective Effect of Caffeic Acid Phenethyl Ester in A Mouse Model of Alzheimer's Disease Involves Nrf2/HO-1 Pathway |
| - | in-vivo, | AD, | NA |
| 5927- | CAR, | Neuroprotective Potential and Underlying Pharmacological Mechanism of Carvacrol for Alzheimer’s and Parkinson’s Diseases |
| - | Review, | AD, | NA | - | Review, | Park, | NA |
| 5932- | CAR, | Carvacrol attenuates mucosal barrier impairment and tumorigenesis by regulating gut microbiome |
| - | in-vivo, | IBD, | NA | - | in-vivo, | Park, | NA |
| 5925- | CAR, | Neuroprotective effects of carvacrol against Alzheimer’s disease and other neurodegenerative diseases: A review |
| - | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
| 3879- | Carno, | Daily Carnosine and Anserine Supplementation Alters Verbal Episodic Memory and Resting State Network Connectivity in Healthy Elderly Adults |
| - | Human, | AD, | NA |
| 3873- | Carno, | Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice |
| - | in-vivo, | AD, | NA |
| - | in-vivo, | AD, | NA |
| 6638- | Cen, | Prolonged Treatment with Centella asiatica Improves Memory, Reduces Amyloid-β Pathology, and Activates NRF2-Regulated Antioxidant Response Pathway in 5xFAD Mice |
| - | in-vivo, | AD, | NA |
| 6635- | Cen, | Pharmacokinetics and metabolomics investigation of an orally modified formula of standardized Centella asiatica extract in healthy volunteers |
| - | Trial, | Nor, | NA |
| 6636- | Cen, | Pharmacokinetics and Pharmacodynamics of Key Components of a Standardized Centella asiatica Product in Cognitively Impaired Older Adults: A Phase 1, Double-Blind, Randomized Clinical Trial |
| - | Trial, | AD, | NA |
| 6639- | Cen, | Centella asiatica Alters Metabolic Pathways Associated With Alzheimer’s Disease in the 5xFAD Mouse Model of ß-Amyloid Accumulation |
| - | in-vivo, | AD, | NA |
| 6662- | Cen, | Assessment report on Centella asiatica (L.) Urban, herba |
| - | Review, | Nor, | NA |
| 6661- | Cen, | Centella asiatica - A review of its medicinal uses and pharmacological effects |
| - | Review, | AD, | NA | - | Review, | Var, | NA |
| 6656- | Cen, | Recent insights into therapeutic potential and nanostructured carrier systems of Centella asiatica: An evidence-based review |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 6655- | Cen, | Centella asiatica improves cognitive function and alters the hippocampal metabolome of aged Tg2576 and wild-type mice |
| - | in-vivo, | AD, | NA |
| 6647- | Cen, | Protective effects of Centella asiatica extract on spatial memory and learning deficits in animal model of systemic inflammation induced by lipopolysaccharide |
| - | in-vivo, | AD, | NA |
| 6648- | Cen, | Centella asiatica (L.) Urban: From Traditional Medicine to Modern Medicine with Neuroprotective Potential |
| - | Review, | AD, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:558 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid